Circulating microRNAs as potential diagnostic biomarkers and therapeutic targets in gastric cancer: Current status and future perspectives

Current Medicinal Chemistry

Volumn 23, Issue 36, 2016, Pages 4135-4150

  Mirzaei, Hamed ^a   Khataminfar, Sara ^a   Mohammadparast, Saeid ^b   ShahidSales, Soudabeh ^c   Maftouh, Mina ^b   Mohammadi, Mohsen ^d   Simonian, Miganoosh ^e   Parizadeh, Seyed Mohammd Reza ^a   Hassanian, Seyed Mahdi ^a   Avan, Amir ^a,c  

^a MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Mashhad University of Medical Sciences ^*  (Iran)

^c MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d LORESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Circulating biomarker; Gastric cancer; MiRNA; Tissue specific biomarker

Indexed keywords

MICRORNA; TUMOR MARKER;

CANCER PROGNOSIS; CANCER STAGING; EARLY CANCER DIAGNOSIS; HUMAN; NONHUMAN; PATIENT MONITORING; PREDICTION; REVIEW; STOMACH CANCER; TISSUE SPECIFICITY; TREATMENT RESPONSE; BLOOD; DISEASE COURSE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; PROGNOSIS; STOMACH NEOPLASMS;

BIOMARKERS, TUMOR; DISEASE PROGRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MICRORNAS; PROGNOSIS; STOMACH NEOPLASMS;

EID: 85006724968     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/0929867323666160818093854     Document Type: Review

References (154)

1. Jemal, A.; Bray, F.; Center, M.M.; Ferlay, J.; Ward, E.; Forman, D. Global cancer statistics. CA Cancer J. Clin., 2011, 61(2), 69-90.
2. Correa, P. Gastric cancer: overview. Gastroenterol. Clin. North Am., 2013, 42(2), 211-217.
3. Guggenheim, D.E.; Shah, M.A. Gastric cancer epidemiology and risk factors. J. Surg. Oncol., 2013, 107(3), 230-236.
4. Link, A.; Kupcinskas, J.; Wex, T.; Malfertheiner, P. Macrorole of microRNA in gastric cancer. Dig. Dis., 2012, 30(3), 255-267.
5. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics, 2010. CA Cancer J. Clin., 2010, 60(5), 277-300.
6. Siegel, R.; Naishadham, D.; Jemal, A. Cancer statistics, 2012. CA Cancer J. Clin., 2012, 62(1), 10-29.
7. Smyth, E.C.; Cunningham, D. Targeted therapy for gastric cancer. Curr. Treat. Options Oncol., 2012, 13(3), 377-389.
8. Kulig, J.; Kolodziejczyk, P.; Kulig, P.; Legutko, J. Targeted therapy for gastric cancer-current status. J. Oncol. Pharm. Pract., 2013, 19(1), 75-81.
9. Zhang, Z.; Li, Z.; Li, Y.; Zang, A. MicroRNA and signaling pathways in gastric cancer. Cancer Gene Ther., 2014, 21(8), 305-316.
10. Wadhwa, R.; Song, S.; Lee, J-S.; Yao, Y.; Wei, Q.; Ajani, J.A. Gastric cancer-molecular and clinical dimensions. Nat. Rev. Clin. Oncol., 2013, 10(11), 643-655.
11. Yin, Y.; Li, J.; Chen, S.; Zhou, T.; Si, J. MicroRNAs as diagnostic biomarkers in gastric cancer. Int. J. Mol. Sci., 2012, 13(10), 12544-12555.
12. Ruan, K.; Fang, X.; Ouyang, G. MicroRNAs: novel regulators in the hallmarks of human cancer. Cancer Lett., 2009, 285(2), 116-126.
13. Wang, Z.; Yang, C. Circulating microRNAs as diagnostic and prognostic biomarkers for gastric cancer-opportunities and challenges. Am. J. Dig. Dis., 2014, 1(1), 44-49.
14. Wu, H.; Huang, M.; Lu, M.; Zhu, W.; Shu, Y.; Cao, P.; Liu, P. Regulation of microtubule-associated protein tau (MAPT) by miR-34c-5p determines the chemosensitivity of gastric cancer to paclitaxel. Cancer Chemother. Pharmacol., 2013, 71(5), 1159-1171.
15. Zhou, H.; Xiao, B.; Zhou, F.; Deng, H.; Zhang, X.; Lou, Y.; Gong, Z.; Du, C.; Guo, J. MiR-421 is a functional marker of circulating tumor cells in gastric cancer patients. Biomarkers, 2012, 17(2), 104-110.
16. Wu, J.; Li, G.; Yao, Y.; Wang, Z.; Sun, W.; Wang, J. MicroRNA- 421 is a new potential diagnosis biomarker with higher sensitivity and specificity than carcinoembryonic antigen and cancer antigen 125 in gastric cancer. Biomarkers, 2015, 20(1), 58-63.
17. Xin, S-Y.; Feng, X-S.; Zhou, L-Q.; Sun, J-J.; Gao, X-L.; Yao, G-L. Reduced expression of circulating microRNA- 218 in gastric cancer and correlation with tumor invasion and prognosis. World J. Gastroenterol., 2014, 20(22), 6906-6911.
18. Tsujiura, M.; Komatsu, S.; Ichikawa, D.; Shiozaki, A.; Konishi, H.; Takeshita, H.; Moriumura, R.; Nagata, H.; Kawaguchi, T.; Hirajima, S.; Arita, T.; Fujiwara, H.; Okamoto, K.; Otsuji, E. Circulating miR-18a in plasma contributes to cancer detection and monitoring in patients with gastric cancer. Gastric Cancer, 2015, 18(2), 271-279.
19. Su, Z-X.; Zhao, J.; Rong, Z-H.; Wu, Y-G.; Geng, W-M.; Qin, C-K. Diagnostic and prognostic value of circulating miR-18a in the plasma of patients with gastric cancer. Tumour Biol., 2014, 35(12), 12119-12125.
20. Zheng, Y.; Cui, L.; Sun, W.; Zhou, H.; Yuan, X.; Huo, M. MicroRNA-21 is a new marker of circulating tumor cells in gastric cancer patients. Cancer biomarkers: section. Dis. Markers, 2010, 10(2), 71-77.
21. Zhang, Z.; Li, Z.; Gao, C.; Chen, P.; Chen, J.; Liu, W.; Xiao, S.; Lu, H. miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab. Invest., 2008, 88(12), 1358-1366.
22. Tsujiura, M.; Ichikawa, D.; Komatsu, S.; Shiozaki, A.; Takeshita, H.; Kosuga, T.; Konishi, H.; Morimura, R.; Deguchi, K.; Fujiwara, H.; Okamoto, K.; Otsuji, E. Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer, 2010, 102(7), 1174-1179.
23. Wang, H.; Wang, L.; Wu, Z.; Sun, R.; Jin, H.; Ma, J.; Liu, L.; Ling, R.; Yi, J.; Wang, L.; Bian, J.; Chen, J.; Li, N.; Yuan, S.; Yun, J. Three dysregulated microRNAs in serum as novel biomarkers for gastric cancer screening. Med. Oncol., 2014, 31(12), 298.
24. Tsai, K.W.; Liao, Y.L.; Wu, C.W.; Hu, L.Y.; Li, S.C.; Chan, W.C.; Ho, M.R.; Lai, C.H.; Kao, H.W.; Fang, W.L.; Huang, K.H.; Lin, W.C. Aberrant expression of miR-196a in gastric cancers and correlation with recurrence. Genes Chromosomes Cancer, 2012, 51(4), 394-401.
25. Zhang, W-H.; Gui, J-H.; Wang, C-Z.; Chang, Q.; Xu, S-P.; Cai, C-H.; Li, Y.N.; Tian, Y.P.; Yan, L.; Wu, B. The identification of miR-375 as a potential biomarker in distal gastric adenocarcinoma. Oncol. Res., 2012, 20(4), 139-147.
26. Zeng, Q.; Jin, C.; Chen, W.; Xia, F.; Wang, Q.; Fan, F.; Du, J.; Guo, Y.; Lin, C.; Yang, K.; Li, J.; Peng, X.; Li, X.; Cao, K. Downregulation of serum miR-17 and miR-106b levels in gastric cancer and benign gastric diseases. Chin. J. Cancer Res., 2014, 26(6), 711-716.
27. Song, J.; Bai, Z.; Han, W.; Zhang, J.; Meng, H.; Bi, J.; Ma, X.; Han, S.; Zhang, Z. Identification of suitable reference genes for qPCR analysis of serum microRNA in gastric cancer patients. Dig. Dis. Sci., 2012, 57(4), 897-904.
28. Song, M.Y.; Pan, K.F.; Su, H.J.; Zhang, L.; Ma, J.L.; Li, J.Y.; Yuasa, Y.; Kang, D.; Kim, Y.S.; You, W.C. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One, 2012, 7(3), e33608.
29. Liu, R.; Zhang, C.; Hu, Z.; Li, G.; Wang, C.; Yang, C.; Huang, D.; Chen, X.; Zhang, H.; Zhuang, R.; Deng, T.; Liu, H.; Yin, J.; Wang, S.; Zen, K.; Ba, Y.; Zhang, C.Y. A fivemicroRNA signature identified from genome-wide serum microRNA expression profiling serves as a fingerprint for gastric cancer diagnosis. Eur. J. Cancer, 2011, 47(5), 784-791.
30. Zhou, X.; Zhu, W.; Li, H.; Wen, W.; Cheng, W.; Wang, F.; Wu, Y.; Qi, L.; Fan, Y.; Chen, Y.; Ding, Y.; Xu, J.; Qian, J.; Huang, Z.; Wang, T.; Zhu, D.; Shu, Y.; Liu, P. Diagnostic value of a plasma microRNA signature in gastric cancer: a microRNA expression analysis. Sci. Rep., 2015, 5, 11251.
31. Valladares-Ayerbes, M.; Reboredo, M.; Medina-Villaamil, V.; Iglesias-Diaz, P.; Lorenzo-Patino, M.J.; Haz, M.; Santamarina, I.; Blanco, M.; Fernandez-Tajes, J.; Quindos, M.; Carral, A.; Figueroa, A.; Anton-Aparicio, L.M.; Calvo, L. Circulating miR-200c as a diagnostic and prognostic biomarker for gastric cancer. J. Transl. Med., 2012, 10(1), 186.
32. Kim, S.Y.; Jeon, T.Y.; Choi, C.I.; Kim, D.H.; Kim, D.H.; Kim, G.H.; Ryu, D.Y.; Lee, B.E.; Kim, H.H. Validation of circulating miRNA biomarkers for predicting lymph node metastasis in gastric cancer. J. Mol. Diagn., 2013, 15(5), 661-669.
33. Fu, Z.; Qian, F.; Yang, X.; Jiang, H.; Chen, Y.; Liu, S. Circulating miR-222 in plasma and its potential diagnostic and prognostic value in gastric cancer. Med. Oncol., 2014, 31(9), 164.
34. Yuan, R.; Wang, G.; Zhi, Q.; Chen, H.; Han, Y.; Wang, B. Up-regulated circulating miR-106a by DNA methylation promised a potential diagnostic and prognostic marker for gastric cancer. Anticancer. Agents Med. Chem., 2015.
35. Liu, H.; Zhu, L.; Liu, B.; Yang, L.; Meng, X.; Zhang, W.; Ma, Y.; Xiao, H. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett., 2012, 316(2), 196-203.
36. Song, M.Y.; Pan, K.F.; Su, H.J.; Zhang, L.; Ma, J.L.; Li, J.Y.; Yuasa, Y.; Kang, D.; Kim, Y.S.; You, W.C. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One, 2012, 7(3), e33608.
37. Li, B.S.; Zhao, Y.L.; Guo, G.; Li, W.; Zhu, E.D.; Luo, X.; Mao, X.H.; Zou, Q.M.; Yu, P.W.; Zuo, Q.F.; Li, N.; Tang, B.; Liu, K.Y.; Xiao, B. Plasma microRNAs, miR-223, miR- 21 and miR-218, as novel potential biomarkers for gastric cancer detection. PLoS One, 2012, 7(7), e41629.
38. Cui, M-H.; Hou, X-L.; Lei, X-Y.; Mu, F-H.; Yang, G-B.; Yue, L.; Fu, Y.; Yi, G.X. Upregulation of microRNA 181c expression in gastric cancer tissues and plasma. Asian Pac. J. Cancer Prev., 2013, 14(5), 3063-3066.
39. Zhou, H.; Guo, J-M.; Lou, Y-R.; Zhang, X-J.; Zhong, F-D.; Jiang, Z.; Cheng, J.; Xiao, B.X. Detection of circulating tumor cells in peripheral blood from patients with gastric cancer using microRNA as a marker. J. Mol. Med., 2010, 88(7), 709-717.
40. Zhang, K-C.; Xi, H-Q.; Cui, J-X.; Shen, W-S.; Li, J-Y.; Wei, B.; Chen, L. Hemolysis-free plasma miR-214 as novel biomarker of gastric cancer and is correlated with distant metastasis. Am. J. Cancer Res., 2015, 5(2), 821-829.
41. Chen, Q.; Ge, X.; Zhang, Y.; Xia, H.; Yuan, D.; Tang, Q.; Chen, L.; Pang, X.; Leng, W.; Bi, F. Plasma miR-122 and miR-192 as potential novel biomarkers for the early detection of distant metastasis of gastric cancer. Oncol. Rep., 2014, 31(4), 1863-1870.
42. Rotkrua, P.; Shimada, S.; Mogushi, K.; Akiyama, Y.; Tanaka, H.; Yuasa, Y. Circulating microRNAs as biomarkers for early detection of diffuse-type gastric cancer using a mouse model. Br. J. Cancer, 2013, 108(4), 932-940.
43. Konishi, H.; Ichikawa, D.; Komatsu, S.; Shiozaki, A.; Tsujiura, M.; Takeshita, H.; Morimura, R.; Nagata, H.; Arita, T.; Kawaguchi, T.; Hirashima, S.; Fujiwara, H.; Okamoto, K.; Otsuji, E. Detection of gastric cancer-associated microRNAs on microRNA microarray comparing pre- and post-operative plasma. Br. J. Cancer, 2012, 106(4), 740-747.
44. Zhu, C.; Ren, C.; Han, J.; Ding, Y.; Du, J.; Dai, N.; Dai, J.; Ma, H.; Hu, Z.; Shen, H.; Xu, Y.; Jin, G. A five-microRNA panel in plasma was identified as potential biomarker for early detection of gastric cancer. Br. J. Cancer, 2014, 110(9), 2291-2299.
45. Yan, C.; Yu, J.C. Application of Mir-301a in the prediction of chemosensitivity and evaluation of the effect of neoadjuvant chemotherapy in gastric cancer. Transl. Gastrointest. Cancer, 2015, 4(S1), AB15. doi: 10.3978/j.issn.2224- 4778.2015.s015
46. AN X-w, ZHANG S-b, XIE X-w, HE F, LONG Y-p. Expression of microRNA-100 in serum of gastric cancer patients [J]. J. Xinxiang Med. Univ., 2013, 5, 019.
47. Li, B.; Zuo, Q.; Zhao, Y.; Xiao, B.; Zhuang, Y.; Mao, X. MicroRNA-25 promotes gastric cancer migration, invasion and proliferation by directly targeting transducer of ERBB2, 1 and correlates with poor survival. Oncogene, 2014.
48. Li, C.; Li, J.F.; Cai, Q.; Qiu, Q.Q.; Yan, M.; Liu, B.Y.; Zhu, Z.G. miRNA-199a-3p in plasma as a potential diagnostic biomarker for gastric cancer. Ann. Surg. Oncol., 2013, 20(3)(Suppl. 3), S397-S405.
49. Gorur, A.; Balci Fidanci, S.; Dogruer Unal, N.; Ayaz, L.; Akbayir, S.; Yildirim Yaroglu, H.; Dirlik, M.; Serin, M.S.; Tamer, L. Determination of plasma microRNA for early detection of gastric cancer. Mol. Biol. Rep., 2013, 40(3), 2091-2096.
50. Xu, Q.; Dong, Q.G.; Sun, L.P.; He, C.Y.; Yuan, Y. Expression of serum miR-20a-5p, let-7a, and miR-320a and their correlations with pepsinogen in atrophic gastritis and gastric cancer: a case-control study. BMC Clin. Pathol., 2013, 13(1), 11.
51. Imaoka, H.; Toiyama, Y.; Okigami, M.; Yasuda, H.; Saigusa, S.; Ohi, M. Circulating microRNA-203 predicts metastases, early recurrence, and poor prognosis in human gastric cancer. Gastric Cancer, 2016,19(3), 744-753.
52. Zhang, J.; Song, Y.; Zhang, C.; Zhi, X.; Fu, H.; Ma, Y.; Chen, Y.; Pan, F.; Wang, K.; Ni, J.; Jin, W.; He, X.; Su, H.; Cui, D. Circulating MiR-16-5p and MiR-19b-3p as two novel potential biomarkers to indicate progression of gastric cancer. Theranostics, 2015, 5(7), 733-745.
53. Zhang, R.; Wang, W.; Li, F.; Zhang, H.; Liu, J. MicroRNA- 106b~25 expressions in tumor tissues and plasma of patients with gastric cancers. Med. Oncol., 2014, 31(10), 243.
54. Wang, W.N.; Chen, Y.; Zhang, Y.D.; Hu, T.H. The regulatory mechanism of CCR7 gene expression and its involvement in the metastasis and progression of gastric cancer. Tumour Biol., 2013, 34(3), 1865-1871.
55. Wu, W.K.; Lee, C.W.; Cho, C.H.; Fan, D.; Wu, K.; Yu, J.; Sung, J.J. MicroRNA dysregulation in gastric cancer: a new player enters the game. Oncogene, 2010, 29(43), 5761-5771.
56. Katada, T.; Ishiguro, H.; Kuwabara, Y.; Kimura, M.; Mitui, A.; Mori, Y.; Ogawa, R.; Harata, K.; Fujii, Y. microRNA expression profile in undifferentiated gastric cancer. Int. J. Oncol., 2009, 34(2), 537-542.
57. Mu, Y.P.; Tang, S.; Sun, W.J.; Gao, W.M.; Wang, M.; Su, X.L. Association of miR-193b down-regulation and miR- 196a up-regulation with clinicopathological features and prognosis in gastric cancer. Asian Pac. J. Cancer Prev., 2014, 15(20), 8893-8900.
58. Luo, H.; Zhang, H.; Zhang, Z.; Zhang, X.; Ning, B.; Guo, J. Down-regulated miR-9 and miR-433 in human gastric carcinoma. J. Exp. Clin. Cancer Res., 2009, 28, 82. doi: 10.1186/1756-9966-28-82.
59. Li, T.; Lu, Y.Y.; Zhao, X.D.; Guo, H.Q.; Liu, C.H.; Li, H.; Zhou, L.; Han, Y.N.; Wu, K.C.; Nie, Y.Z.; Shi, Y.Q.; Fan, D.M. MicroRNA-296-5p increases proliferation in gastric cancer through repression of Caudal-related homeobox 1. Oncogene, 2014, 33(6), 783-793.
60. Wang, M; Gu, H; Qian, H; Zhu, W; Zhao, C; Zhang, X miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation. Eur. J. Cancer, 2013, 49(8), 2010-2021.
61. Ueda, T.; Volinia, S.; Okumura, H.; Shimizu, M.; Taccioli, C.; Rossi, S.; Alder, H.; Liu, C.G.; Oue, N.; Yasui, W.; Yoshida, K.; Sasaki, H.; Nomura, S.; Seto, Y.; Kaminishi, M.; Calin, G.A.; Croce, C.M. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol., 2010, 11(2), 136-146.
62. Liu, K.; Qian, T.; Tang, L.; Wang, J.; Yang, H.; Ren, J. Decreased expression of microRNA let-7i and its association with chemotherapeutic response in human gastric cancer. World J. Surg. Oncol., 2012, 10, 225.
63. Li, Z.; Li, D.; Zhang, G.; Xiong, J.; Jie, Z.; Cheng, H.; Cao, Y.; Jiang, M.; Lin, L.; Le, Z.; Tan, S.; Zou, W.; Gong, B.; Lin, S.; Yang, K. Methylation-associated silencing of MicroRNA- 335 contributes tumor cell invasion and migration by interacting with RASA1 in gastric cancer. Am. J. Cancer Res., 2014, 4(6), 648-662.
64. Ueda, T.; Volinia, S.; Okumura, H.; Shimizu, M.; Taccioli, C.; Rossi, S.; Alder, H.; Liu, C.G.; Oue, N.; Yasui, W.; Yoshida, K.; Sasaki, H.; Nomura, S.; Seto, Y.; Kaminishi, M.; Calin, G.A.; Croce, C.M. Relation between microRNA expression and progression and prognosis of gastric cancer: a microRNA expression analysis. Lancet Oncol., 2010, 11(2), 136-146.
65. Motoyama, K.; Inoue, H.; Mimori, K.; Tanaka, F.; Kojima, K.; Uetake, H.; Sugihara, K.; Mori, M. Clinicopathological and prognostic significance of PDCD4 and microRNA-21 in human gastric cancer. Int. J. Oncol., 2010, 36(5), 1089-1095.
66. Liu, K.; Li, G.; Fan, C.; Diao, Y.; Wu, B.; Li, J. Increased Expression of MicroRNA-221 in gastric cancer and its clinical significance. J. Int. Med. Res., 2012, 40(2), 467-474.
67. Inoue, T.; Iinuma, H.; Ogawa, E.; Inaba, T.; Fukushima, R. Clinicopathological and prognostic significance of microRNA- 107 and its relationship to DICER1 mRNA expression in gastric cancer. Oncol. Rep., 2012, 27(6), 1759-1764.
68. Xiao, B.; Guo, J.; Miao, Y.; Jiang, Z.; Huan, R.; Zhang, Y.; Li, D.; Zhong, J. Detection of miR-106a in gastric carcinoma and its clinical significance. Clin. Chim. Acta, 2009, 400(1-2), 97-102.
69. Jiang, Z.; Guo, J.; Xiao, B.; Miao, Y.; Huang, R.; Li, D.; Zhang, Y. Increased expression of miR-421 in human gastric carcinoma and its clinical association. J. Gastroenterol., 2010, 45(1), 17-23.
70. Li, X.; Zhang, Y.; Zhang, H.; Liu, X.; Gong, T.; Li, M.; Sun, L.; Ji, G.; Shi, Y.; Han, Z.; Han, S.; Nie, Y.; Chen, X.; Zhao, Q.; Ding, J.; Wu, K.; Daiming, F. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res., 2011, 9(7), 824-833.
71. Donzelli, S.; Mori, F.; Biagioni, F.; Bellissimo, T.; Pulito, C.; Muti, P.; Strano, S.; Blandino, G. MicroRNAs: short non-coding players in cancer chemoresistance. Mol. Cell. Ther., 2014, 2, 16.
72. Naito, Y.; Sakamoto, N.; Oue, N.; Yashiro, M.; Sentani, K.; Yanagihara, K.; Hirakawa, K.; Yasui, W. MicroRNA-143 regulates collagen type III expression in stromal fibroblasts of scirrhous type gastric cancer. Cancer Sci., 2014, 105(2), 228-235.
73. Naito, Y.; Yasuno, K.; Tagawa, H.; Sakamoto, N.; Oue, N.; Yashiro, M.; Sentani, K.; Goto, K.; Shinmei, S.; Oo, H.Z.; Yanagihara, K.; Hirakawa, K.; Yasui, W. MicroRNA-145 is a potential prognostic factor of scirrhous type gastric cancer. Oncol. Rep., 2014, 32(4), 1720-1726.
74. Chu, D.; Zhao, Z.; Li, Y.; Li, J.; Zheng, J.; Wang, W.; Zhao, Q.; Ji, G. Increased microRNA-630 expression in gastric cancer is associated with poor overall survival. PLoS One, 2014, 9(3), e90526.
75. Wang, Y.Y.; Ye, Z.Y.; Zhao, Z.S.; Li, L.; Wang, Y.X.; Tao, H.Q.; Wang, H.J.; He, X.J. Clinicopathologic significance of miR-10b expression in gastric carcinoma. Hum. Pathol., 2013, 44(7), 1278-1285.
76. Liu, X.; Yu, H.; Cai, H.; Wang, Y. The expression and clinical significance of miR-132 in gastric cancer patients. Diagn. Pathol., 2014, 9, 57.
77. Lim, J.Y.; Yoon, S.O.; Seol, S-Y.; Hong, S.W.; Kim, J.W.; Choi, S.H. Overexpression of miR-196b and HOXA10 characterize a poor-prognosis gastric cancer subtype. Cancer Res., 2013, 73(8)(Suppl.), 1961.
78. Xu, Y.J.; Fan, Y. MiR-215/192 participates in gastric cancer progression. Clin. Transl. Oncol., 2015, 17(1), 34-40.
79. Ma, X.Q.; Wang, L.P.; Luo, Q.C.; Cai, J.C. Relationship between the expression level of miR-29c and biological behavior of gastric cancer. Zhonghua Zhong Liu Za Zhi, 2013, 35(5), 325-330.
80. Wu, J.G.; Wang, J.J.; Jiang, X.; Lan, J.P.; He, X.J.; Wang, H-J. MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis. Gastric Cancer, 2015, 18(4), 729-739. doi: 10.1007/s10120-014-0421-8.
81. Jiang, H.; Yu, W.W.; Wang, L.L.; Peng, Y. miR-130a acts as a potential diagnostic biomarker and promotes gastric cancer migration, invasion and proliferation by targeting RUNX3. Oncol. Rep., 2015, 34(3), 1153-1161.
82. Jiang, J.; Zheng, X.; Xu, X.; Zhou, Q.; Yan, H.; Zhang, X.; Lu, B.; Wu, C.; Ju, J. Prognostic significance of miR-181b and miR-21 in gastric cancer patients treated with S- 1/Oxaliplatin or Doxifluridine/Oxaliplatin. PLoS One, 2011, 6(8), e23271.
83. Xu, X.D.; He, X.J.; Tao, H.Q.; Zhang, W.; Wang, Y.Y.; Ye, Z.Y.; Zhao, Z.S. Abnormal expression of miR-301a in gastric cancer associated with progression and poor prognosis. J. Surg. Oncol., 2013, 108(3), 197-202.
84. Chen, L.; Jiang, M.; Yuan, W.; Tang, H. Prognostic value of miR-93 overexpression in resectable gastric adenocarcinomas. Acta Gastroenterol. Belg., 2012, 75(1), 22-27.
85. Katada, T.; Ishiguro, H.; Kuwabara, Y.; Kimura, M.; Mitui, A.; Mori, Y.; Ogawa, R.; Harata, K.; Fujii, Y. microRNA expression profile in undifferentiated gastric cancer. Int. J. Oncol., 2009, 34(2), 537-542.
86. Li, X.; Zhang, Y.; Zhang, H.; Liu, X.; Gong, T.; Li, M.; Sun, L.; Ji, G.; Shi, Y.; Han, Z.; Han, S.; Nie, Y.; Chen, X.; Zhao, Q.; Ding, J.; Wu, K.; Daiming, F. miRNA-223 promotes gastric cancer invasion and metastasis by targeting tumor suppressor EPB41L3. Mol. Cancer Res., 2011, 9(7), 824-833.
87. Guo, J.; Miao, Y.; Xiao, B.; Huan, R.; Jiang, Z.; Meng, D.; Wang, Y. Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. J. Gastroenterol. Hepatol., 2009, 24(4), 652-657.
88. Carvalho, J.; van Grieken, N.C.; Pereira, P.M.; Sousa, S.; Tijssen, M.; Buffart, T.E.; Diosdado, B.; Grabsch, H.; Santos, M.A.; Meijer, G.; Seruca, R.; Carvalho, B.; Oliveira, C. Lack of microRNA-101 causes E-cadherin functional deregulation through EZH2 up-regulation in intestinal gastric cancer. J. Pathol., 2012, 228(1), 31-44.
89. Tseng, C.W.; Lin, C.C.; Chen, C.N.; Huang, H.C.; Juan, H.F. Integrative network analysis reveals active microRNAs and their functions in gastric cancer. BMC Syst. Biol., 2011, 5(1), 99.
90. Chen, Y.; Song, Y.; Wang, Z.; Yue, Z.; Xu, H.; Xing, C.; Liu, Z. Altered expression of MiR-148a and MiR-152 in gastrointestinal cancers and its clinical significance. J. Gastrointest. Surg., 2010, 14(7), 1170-1179.
91. Kurashige, J.; Kamohara, H.; Watanabe, M.; Hiyoshi, Y.; Iwatsuki, M.; Tanaka, Y.; Kinoshita, K.; Saito, S.; Baba, Y.; Baba, H. MicroRNA-200b regulates cell proliferation, invasion, and migration by directly targeting ZEB2 in gastric carcinoma. Ann. Surg. Oncol., 2012, 19(3)(Suppl. 3), S656-S664.
92. Xing, A.Y.; Wang, Y.W.; Su, Z.X.; Shi, D.B.; Wang, B.; Gao, P. Catenin-δ1, negatively regulated by miR-145, promotes tumour aggressiveness in gastric cancer. J. Pathol., 2015, 236(1), 53-64.
93. Gao, P.; Xing, A.Y.; Zhou, G.Y.; Zhang, T.G.; Zhang, J.P.; Gao, C.; Li, H.; Shi, D.B. The molecular mechanism of microRNA- 145 to suppress invasion-metastasis cascade in gastric cancer. Oncogene, 2013, 32(4), 491-501.
94. Bandres, E.; Bitarte, N.; Arias, F.; Agorreta, J.; Fortes, P.; Agirre, X.; Zarate, R.; Diaz-Gonzalez, J.A.; Ramirez, N.; Sola, J.J.; Jimenez, P.; Rodriguez, J.; Garcia-Foncillas, J. microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin. Cancer Res., 2009, 15(7), 2281-2290.
95. Nishida, N.; Mimori, K.; Fabbri, M.; Yokobori, T.; Sudo, T.; Tanaka, F.; Shibata, K.; Ishii, H.; Doki, Y.; Mori, M. MicroRNA-125a-5p is an independent prognostic factor in gastric cancer and inhibits the proliferation of human gastric cancer cells in combination with trastuzumab. Clin. Cancer Res., 2011, 17(9), 2725-2733.
96. Zheng, B.; Liang, L.; Huang, S.; Zha, R.; Liu, L.; Jia, D.; Tian, Q.; Wang, Q.; Wang, C.; Long, Z.; Zhou, Y.; Cao, X.; Du, C.; Shi, Y.; He, X. MicroRNA-409 suppresses tumour cell invasion and metastasis by directly targeting radixin in gastric cancers. Oncogene, 2012, 31(42), 4509-4516.
97. Li, X.; Zhang, Y.; Zhang, Y.; Ding, J.; Wu, K.; Fan, D. Survival prediction of gastric cancer by a seven-microRNA signature. Gut, 2010, 59(5), 579-585.
98. Feng, R.; Chen, X.; Yu, Y.; Su, L.; Yu, B.; Li, J.; Cai, Q.; Yan, M.; Liu, B.; Zhu, Z. miR-126 functions as a tumour suppressor in human gastric cancer. Cancer Lett., 2010, 298(1), 50-63.
99. Zhang, Y.; Guo, J.; Li, D.; Xiao, B.; Miao, Y.; Jiang, Z.; Zhuo, H. Down-regulation of miR-31 expression in gastric cancer tissues and its clinical significance. Med. Oncol., 2010, 27(3), 685-689.
100. Sakamoto, N.; Naito, Y.; Oue, N.; Sentani, K.; Uraoka, N.; Zarni Oo, H.; Yanagihara, K.; Aoyagi, K.; Sasaki, H.; Yasui, W. MicroRNA-148a is downregulated in gastric cancer, targets MMP7, and indicates tumor invasiveness and poor prognosis. Cancer Sci., 2014, 105(2), 236-243.
101. Chiang, Y.; Zhou, X.; Wang, Z.; Song, Y.; Liu, Z.; Zhao, F.; Zhu, J.; Xu, H. Expression levels of microRNA-192 and -215 in gastric carcinoma. Pathol. Oncol. Res., 2012, 18(3), 585-591.
102. Wang, W.; Li, F.; Zhang, Y.; Tu, Y.; Yang, Q.; Gao, X. Reduced expression of miR-22 in gastric cancer is related to clinicopathologic characteristics or patient prognosis. Diagn. Pathol., 2013, 8, 102.
103. Tan, Z.; Jiang, H.; Wu, Y.; Xie, L.; Dai, W.; Tang, H.; Tang, S. miR-185 is an independent prognosis factor and suppresses tumor metastasis in gastric cancer. Mol. Cell. Biochem., 2014, 386(1-2), 223-231.
104. Yang, Q.; Zhang, C.; Huang, B.; Li, H.; Zhang, R.; Huang, Y.; Wang, J. Downregulation of microRNA-206 is a potent prognostic marker for patients with gastric cancer. Eur. J. Gastroenterol. Hepatol., 2013, 25(8), 953-957.
105. Zhang, Z.; Sun, J.; Bai, Z.; Li, H.; He, S.; Chen, R.; Che, X. MicroRNA-153 acts as a prognostic marker in gastric cancer and its role in cell migration and invasion. Onco Targets Ther., 2015, 8, 357-364.
106. Kogo, R.; Mimori, K.; Tanaka, F.; Komune, S.; Mori, M. Clinical significance of miR-146a in gastric cancer cases. Clin. Cancer Res., 2011, 17(13), 4277-4284.
107. Tang, H.; Deng, M.; Tang, Y.; Xie, X.; Guo, J.; Kong, Y.; Ye, F.; Su, Q.; Xie, X. miR-200b and miR-200c as prognostic factors and mediators of gastric cancer cell progression. Clin. Cancer Res., 2013, 19(20), 5602-5612.
108. Chen, H.; Ren, C.; Han, C.; Wang, D.; Chen, Y.; Fu, D. Expression and prognostic value of miR-486-5p in patients with gastric adenocarcinoma. PLoS One, 2015, 10(3), e0119384.
109. Sakimura, S.; Sugimachi, K.; Kurashige, J.; Ueda, M.; Hirata, H.; Nambara, S.; Komatsu, H.; Saito, T.; Takano, Y.; Uchi, R.; Sakimura, E.; Shinden, Y.; Iguchi, T.; Eguchi, H.; Oba, Y.; Hoka, S.; Mimori, K. The miR-506-induced epithelial-mesenchymal transition is involved in poor prognosis for patients with gastric cancer. Ann. Surg. Oncol., 2015, 22(Suppl. 3), S1436-S1443.
110. Hashiguchi, Y.; Nishida, N.; Mimori, K.; Sudo, T.; Tanaka, F.; Shibata, K.; Ishii, H.; Mochizuki, H.; Hase, K.; Doki, Y.; Mori, M. Down-regulation of miR-125a-3p in human gastric cancer and its clinicopathological significance. Int. J. Oncol., 2012, 40(5), 1477-1482.
111. Zheng, Y.; Li, S.; Ding, Y.; Wang, Q.; Luo, H.; Shi, Q.; Hao, Z.; Xiao, G.; Tong, S. The role of miR-18a in gastric cancer angiogenesis. Hepatogastroenterology, 2013, 60(127), 1809-1813.
112. Wu, Q.; Luo, G.; Yang, Z.; Zhu, F.; An, Y.; Shi, Y.; Fan, D. miR-17-5p promotes proliferation by targeting SOCS6 in gastric cancer cells. FEBS Lett., 2014, 588(12), 2055-2062.
113. Li, X.; Zhang, Z.; Yu, M.; Li, L.; Du, G.; Xiao, W.; Yang, H. Involvement of miR-20a in promoting gastric cancer progression by targeting early growth response 2 (EGR2). Int. J. Mol. Sci., 2013, 14(8), 16226-16239.
114. Wang, M.; Li, C.; Yu, B.; Su, L.; Li, J.; Ju, J.; Yu, Y.; Gu, Q.; Zhu, Z.; Liu, B. Overexpressed miR-301a promotes cell proliferation and invasion by targeting RUNX3 in gastric cancer. J. Gastroenterol., 2013, 48(9), 1023-1033.
115. Cho, W.J.; Shin, J.M.; Kim, J.S.; Lee, M.R.; Hong, K.S.; Lee, J.H.; Koo, K.H.; Park, J.W.; Kim, K.S. miR-372 regulates cell cycle and apoptosis of ags human gastric cancer cell line through direct regulation of LATS2. Mol. Cells, 2009, 28(6), 521-527.
116. Wu, J.G.; Wang, J.J.; Jiang, X.; Lan, J.P.; He, X.J.; Wang, H.J.; Ma, Y.Y.; Xia, Y.J.; Ru, G.Q.; Ma, J.; Zhao, Z.S.; Zhou, R. MiR-125b promotes cell migration and invasion by targeting PPP1CA-Rb signal pathways in gastric cancer, resulting in a poor prognosis. Gastric Cancer, 2015, 18(4), 729-739.
117. Jia, H.; Zhang, Z.; Zou, D.; Wang, B.; Yan, Y.; Luo, M.; Dong, L.; Yin, H.; Gong, B.; Li, Z.; Wang, F.; Song, W.; Liu, C.; Ma, Y.; Zhang, J.; Zhao, H.; Li, J.; Yu, J. MicroRNA- 10a is down-regulated by DNA methylation and functions as a tumor suppressor in gastric cancer cells. PLoS One, 2014, 9(1), e88057.
118. Lai, KW; Koh, KX; Loh, M; Tada, K; Subramaniam, MM; Lim, XY MicroRNA-130b regulates the tumour suppressor RUNX3 in gastric cancer. Eur. J. Cancer, 2010, 46(8), 1456-1463.
119. Deng, H.; Guo, Y.; Song, H.; Xiao, B.; Sun, W.; Liu, Z.; Yu, X.; Xia, T.; Cui, L.; Guo, J. MicroRNA-195 and microRNA- 378 mediate tumor growth suppression by epigenetical regulation in gastric cancer. Gene, 2013, 518(2), 351-359.
120. Liu, Y.; Zhang, X.; Zhang, Y.; Hu, Z.; Yang, D.; Wang, C.; Guo, M.; Cai, Q. Identification of miRNomes in human stomach and gastric carcinoma reveals miR-133b/a-3p as therapeutic target for gastric cancer. Cancer Lett., 2015, 369(1), 58-66.
121. Zhao, Y.; Huang, J.; Zhang, L.; Qu, Y.; Li, J.; Yu, B.; Yan, M.; Yu, Y.; Liu, B.; Zhu, Z. MiR-133b is frequently decreased in gastric cancer and its overexpression reduces the metastatic potential of gastric cancer cells. BMC Cancer, 2014, 14(1), 34.
122. Saito, Y.; Suzuki, H.; Imaeda, H.; Matsuzaki, J.; Hirata, K.; Tsugawa, H.; Hibino, S.; Kanai, Y.; Saito, H.; Hibi, T. The tumor suppressor microRNA-29c is downregulated and restored by celecoxib in human gastric cancer cells. Int. J. Cancer, 2013, 132(8), 1751-1760.
123. Matsuo, M.; Nakada, C.; Tsukamoto, Y.; Noguchi, T.; Uchida, T.; Hijiya, N.; Matsuura, K.; Moriyama, M. MiR- 29c is downregulated in gastric carcinomas and regulates cell proliferation by targeting RCC2. Mol. Cancer, 2013, 12(1), 15.
124. Xiao, B.; Zhu, E-D.; Li, N.; Lu, D-S.; Li, W.; Li, B-S.; Zhao, Y.L.; Mao, X.H.; Guo, G.; Yu, P.W.; Zou, Q.M. Increased miR-146a in gastric cancer directly targets SMAD4 and is involved in modulating cell proliferation and apoptosis. Oncol. Rep., 2012, 27(2), 559-566.
125. Zhou, X.; Xia, Y.; Li, L.; Zhang, G. MiR-101 inhibits cell growth and tumorigenesis of Helicobacter pylori related gastric cancer by repression of SOCS2. Cancer Biol. Ther., 2015, 16(1), 160-169.
126. He, X.P.; Shao, Y.; Li, X.L.; Xu, W.; Chen, G.S.; Sun, H.H.; Xu, H.C.; Xu, X.; Tang, D.; Zheng, X.F.; Xue, Y.P.; Huang, G.C.; Sun, W.H. Downregulation of miR-101 in gastric cancer correlates with cyclooxygenase-2 overexpression and tumor growth. FEBS J., 2012, 279(22), 4201-4212.
127. Cao, W.; Fan, R.; Wang, L.; Cheng, S.; Li, H.; Jiang, J.; Geng, M.; Jin, Y.; Wu, Y. Expression and regulatory function of miRNA-34a in targeting survivin in gastric cancer cells. Tumour Biol., 2013, 34(2), 963-971.
128. Cao, W.; Yang, W.; Fan, R.; Li, H.; Jiang, J.; Geng, M.; Jin, Y.; Wu, Y. miR-34a regulates cisplatin-induce gastric cancer cell death by modulating PI3K/AKT/survivin pathway. Tumour Biol., 2014, 35(2), 1287-1295.
129. Liu, J.; Xue, H.; Zhang, J.; Suo, T.; Xiang, Y.; Zhang, W.; Ma, J.; Cai, D.; Gu, X. MicroRNA-144 inhibits the metastasis of gastric cancer by targeting MET expression. J. Exp. Clin. Cancer Res., 2015, 34(1), 35.
130. Akiyoshi, S.; Fukagawa, T.; Ueo, H.; Ishibashi, M.; Takahashi, Y.; Fabbri, M.; Sasako, M.; Maehara, Y.; Mimori, K.; Mori, M. Clinical significance of miR-144-ZFX axis in disseminated tumour cells in bone marrow in gastric cancer cases. Br. J. Cancer, 2012, 107(8), 1345-1353.
131. Xing, X; Li, Z. [Expression of miR-143 and miR-145 and their functional study in gastric carcinoma]. Zhonghua Wei Chang Wai Ke Za Zhi, 2015, 18(1), 50-53.
132. Liu, W-J.; Xu, Q.; Sun, L-P.; Dong, Q-G.; He, C.Y.; Yuan, Y. Expression of serum let-7c, let-7i, and let-7f microRNA with its target gene, pepsinogen C, in gastric cancer and precancerous disease. Tumour Biol., 2015, 36(5), 3337-3343.
133. Wagner, A.D.; Unverzagt, S.; Grothe, W.; Kleber, G.; Grothey, A.; Haerting, J.; Fleig, W.E. Chemotherapy for advanced gastric cancer. Cochrane Database Syst. Rev., 2010, (3), CD004064.
134. Holohan, C.; Van Schaeybroeck, S.; Longley, D.B.; Johnston, P.G. Cancer drug resistance: an evolving paradigm. Nat. Rev. Cancer, 2013, 13(10), 714-726.
135. Zheng, T.; Wang, J.; Chen, X.; Liu, L. Role of microRNA in anticancer drug resistance. Int. J. Cancer, 2010, 126(1), 2-10.
136. Ma, J.; Dong, C.; Ji, C. MicroRNA and drug resistance. Cancer Gene Ther., 2010, 17(8), 523-531.
137. Zhang, D; Fan, D. Multidrug resistance in gastric cancer: recent research advances and ongoing therapeutic challenges. Expret Rev. Anticancer Ther., 2007, 7(10), 1369-1378.
138. Kim, C.H.; Kim, H.K.; Rettig, R.L.; Kim, J.; Lee, E.T.; Aprelikova, O.; Choi, I.J.; Munroe, D.J.; Green, J.E. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med. Genomics, 2011, 4(1), 79.
139. Xia, L; Zhang, D; Du, R; Pan, Y; Zhao, L; Sun, S miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells. Int. J. Cancer, 2008, 123(2), 372-9.
140. Chen, Y; Zuo, J; Liu, Y; Gao, H; Liu, W. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells. Chin. J. Cancer, 2010, 29(12), 1006-1011.
141. Wu, X.M.; Shao, X.Q.; Meng, X.X.; Zhang, X.N.; Zhu, L.; Liu, S.X.; Lin, J.; Xiao, H.S. Genome-wide analysis of microRNA and mRNA expression signatures in hydroxycamptothecin- resistant gastric cancer cells. Acta Pharmacol. Sin., 2011, 32(2), 259-269.
142. Zhu, W.; Zhu, D.; Lu, S.; Wang, T.; Wang, J.; Jiang, B.; Shu, Y.; Liu, P. miR-497 modulates multidrug resistance of human cancer cell lines by targeting BCL2. Med. Oncol., 2012, 29(1), 384-391.
143. Zhu, W; Shan, X; Wang, T; Shu, Y; Liu, P. miR-181b modulates multidrug resistance by targeting BCL2 in human cancer cell lines. Int. J. Cancer, 2010, 127(11), 2520-2529.
144. Sacconi, A.; Biagioni, F.; Canu, V.; Mori, F.; Di Benedetto, A.; Lorenzon, L.; Ercolani, C.; Di Agostino, S.; Cambria, A.M.; Germoni, S.; Grasso, G.; Blandino, R.; Panebianco, V.; Ziparo, V.; Federici, O.; Muti, P.; Strano, S.; Carboni, F.; Mottolese, M.; Diodoro, M.; Pescarmona, E.; Garofalo, A.; Blandino, G. miR-204 targets Bcl-2 expression and enhances responsiveness of gastric cancer. Cell Death Dis., 2012, 3, e423.
145. Ji, Q.; Hao, X.; Meng, Y.; Zhang, M.; Desano, J.; Fan, D.; Xu, L. Restoration of tumor suppressor miR-34 inhibits human p53-mutant gastric cancer tumorspheres. BMC Cancer, 2008, 8, 266.
146. Zhu, W.; Xu, H.; Zhu, D.; Zhi, H.; Wang, T.; Wang, J.; Jiang, B.; Shu, Y.; Liu, P. miR-200bc/429 cluster modulates multidrug resistance of human cancer cell lines by targeting BCL2 and XIAP. Cancer Chemother. Pharmacol., 2012, 69(3), 723-731.
147. Zhao, X.; Yang, L.; Hu, J. Down-regulation of miR-27a might inhibit proliferation and drug resistance of gastric cancer cells. Journal of experimental & clinical cancer research. J. Exp. Clin. Cancer Res., 2011, 30, 55.
148. Yang, S.M.; Huang, C.; Li, X.F.; Yu, M.Z.; He, Y.; Li, J. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology, 2013, 306, 162-168.
149. Wang, F.; Li, T.; Zhang, B.; Li, H.; Wu, Q.; Yang, L.; Nie, Y.; Wu, K.; Shi, Y.; Fan, D. MicroRNA-19a/b regulates multidrug resistance in human gastric cancer cells by targeting PTEN. Biochem. Biophys. Res. Commun., 2013, 434(3), 688-694.
150. Kim, C.H.; Kim, H.K.; Rettig, R.L.; Kim, J.; Lee, E.T.; Aprelikova, O.; Choi, I.J.; Munroe, D.J.; Green, J.E. miRNA signature associated with outcome of gastric cancer patients following chemotherapy. BMC Med. Genomics, 2011, 4, 79.
151. Shang, Y.; Zhang, Z.; Liu, Z.; Feng, B.; Ren, G.; Li, K.; Zhou, L.; Sun, Y.; Li, M.; Zhou, J.; An, Y.; Wu, K.; Nie, Y.; Fan, D. miR-508-5p regulates multidrug resistance of gastric cancer by targeting ABCB1 and ZNRD1. Oncogene, 2014, 33(25), 3267-3276.
152. Zhang, Y.; Lu, Q.; Cai, X. MicroRNA-106a induces multidrug resistance in gastric cancer by targeting RUNX3. FEBS Lett., 2013, 587(18), 3069-3075.
153. Bandres, E; Bitarte, N; Arias, F; Agorreta, J; Fortes, P; Agirre, X microRNA-451 regulates macrophage migration inhibitory factor production and proliferation of gastrointestinal cancer cells. Clin. Cancer Res., 2009, 15(7), 2281-2290.
154. Zhang, Z; Li, Z; Gao, C; Chen, P; Chen, J; Liu, W miR-21 plays a pivotal role in gastric cancer pathogenesis and progression. Lab Invest., 2008, 88(12), 1358-1366